Published in N Engl J Med on June 21, 2012
Co-infections with Babesia microti and Plasmodium parasites along the China-Myanmar border. Infect Dis Poverty (2013) 1.18
Spatiotemporal dynamics of emerging pathogens in questing Ixodes ricinus. Front Cell Infect Microbiol (2013) 1.07
Babesiosis. Infect Dis Clin North Am (2015) 1.03
Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences. Trends Parasitol (2015) 1.02
Babesia venatorum Infection in Child, China. Emerg Infect Dis (2014) 1.00
Monitoring human babesiosis emergence through vector surveillance New England, USA. Emerg Infect Dis (2014) 0.97
The evolutionary dynamics of variant antigen genes in Babesia reveal a history of genomic innovation underlying host-parasite interaction. Nucleic Acids Res (2014) 0.96
Quantitative PCR for detection of Babesia microti in Ixodes scapularis ticks and in human blood. Vector Borne Zoonotic Dis (2013) 0.91
Tick-borne pathogen - reversed and conventional discovery of disease. Front Public Health (2014) 0.90
Human babesiosis, Maine, USA, 1995-2011. Emerg Infect Dis (2014) 0.88
Whole genome mapping and re-organization of the nuclear and mitochondrial genomes of Babesia microti isolates. PLoS One (2013) 0.88
A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting. Int J Parasitol (2014) 0.87
Co-infection and genetic diversity of tick-borne pathogens in roe deer from Poland. Vector Borne Zoonotic Dis (2013) 0.87
Emergence of human babesiosis along the border of China with Myanmar: detection by PCR and confirmation by sequencing. Emerg Microbes Infect (2014) 0.86
Human babesiosis, an emerging tick-borne disease in the People's Republic of China. Parasit Vectors (2014) 0.86
The first case of locally acquired tick-borne Babesia microti infection in Canada. Can J Infect Dis Med Microbiol (2015) 0.86
Sequence and annotation of the apicoplast genome of the human pathogen Babesia microti. PLoS One (2014) 0.85
Borrelia burgdorferi promotes the establishment of Babesia microti in the northeastern United States. PLoS One (2014) 0.84
Macrophages are the determinant of resistance to and outcome of nonlethal Babesia microti infection in mice. Infect Immun (2014) 0.84
Expression, Purification, and Biological Characterization of Babesia microti Apical Membrane Antigen 1. Infect Immun (2015) 0.83
Babesia microti infection, eastern Pennsylvania, USA. Emerg Infect Dis (2013) 0.82
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion (2014) 0.82
Ixodes persulcatus Ticks as Vectors for the Babesia microti U.S. Lineage in Japan. Appl Environ Microbiol (2016) 0.82
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion (2013) 0.81
Babesia microti: an unusual travel-related disease. BMC Infect Dis (2013) 0.81
Haematologic complications from human babesiosis: a case report. New Microbes New Infect (2015) 0.81
A longitudinal study of Babesia microti infection in seropositive blood donors. Transfusion (2014) 0.81
A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse. Nat Microbiol (2016) 0.81
Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone. J Exp Med (2016) 0.80
Molecular detection and seroprevalence of Babesia microti among stock farmers in Khutul City, Selenge Province, Mongolia. Korean J Parasitol (2014) 0.80
Emergence of babesiosis in China-Myanmar border areas. Parasit Vectors (2015) 0.79
Not "out of Nantucket": Babesia microti in southern New England comprises at least two major populations. Parasit Vectors (2014) 0.79
Prevalence, genetic identity and vertical transmission of Babesia microti in three naturally infected species of vole, Microtus spp. (Cricetidae). Parasit Vectors (2017) 0.79
Human Babesiosis: Pathogens, Prevalence, Diagnosis and Treatment. Curr Clin Microbiol Rep (2015) 0.78
Clofazimine Inhibits the Growth of Babesia and Theileria Parasites In Vitro and In Vivo. Antimicrob Agents Chemother (2016) 0.78
Transfusion-transmitted babesiosis: is it time to screen the blood supply? Curr Opin Hematol (2016) 0.78
Molecular identification of Theileria and Babesia in ticks collected from sheep and goats in the Black Sea region of Turkey. Parasitol Res (2014) 0.78
Identification and Characterization of the Rhoptry Neck Protein 2 in Babesia divergens and B. microti. Infect Immun (2016) 0.77
Experimental transfusion-induced Babesia microti infection: dynamics of parasitemia and immune responses in a rhesus macaque model. Transfusion (2016) 0.77
Invasion of two tick-borne diseases across New England: harnessing human surveillance data to capture underlying ecological invasion processes. Proc Biol Sci (2016) 0.77
Human babesiosis. N Engl J Med (2012) 0.76
Genetic Evidence for Cytochrome b Qi Site Inhibition by 4(1H)-quinolone-3-diarylethers and Antimycin in Toxoplasma gondii. Antimicrob Agents Chemother (2016) 0.76
Babesiosis Occurrence among the Elderly in the United States, as Recorded in Large Medicare Databases during 2006-2013. PLoS One (2015) 0.76
The Utility of Blood and Bone Marrow Films and Trephine Biopsy Sections in the Diagnosis of Parasitic Infections. Mediterr J Hematol Infect Dis (2015) 0.76
Oxidative stress control by apicomplexan parasites. Biomed Res Int (2015) 0.76
Prevalence and phylogenetic analysis of Babesia spp. in Ixodes ricinus and Ixodes persulcatus ticks in Latvia. Exp Appl Acarol (2016) 0.76
Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions. Sci Rep (2016) 0.76
A targeted immunomic approach identifies diagnostic antigens in the human pathogen Babesia microti. Transfusion (2016) 0.76
Babesiosis-associated immune thrombocytopenia. Stem Cell Investig (2017) 0.76
Diagnosis and management of human babesiosis. Trop Parasitol (2015) 0.75
Babesia microti from humans and ticks hold a genomic signature of strong population structure in the United States. BMC Genomics (2016) 0.75
Complete Molecular and Immunoprotective Characterization of Babesia microti Enolase. Front Microbiol (2017) 0.75
Human babesiosis. N Engl J Med (2012) 0.75
Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther (2017) 0.75
Concurrent babesiosis and serological evidence of Lyme disease in a young patient. J Community Hosp Intern Med Perspect (2017) 0.75
Transmission of Babesia microti Parasites by Solid Organ Transplantation. Emerg Infect Dis (2016) 0.75
Experimental transmission of Babesia microti by Rhipicephalus haemaphysaloides. Parasit Vectors (2016) 0.75
Autoimmune hemolytic anemia associated with babesiosis. Biomark Res (2017) 0.75
Exchange transfusion for babesiosis when, how, and how long? Indian J Crit Care Med (2016) 0.75
Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone. Ann Clin Microbiol Antimicrob (2017) 0.75
Molecular detection of vector-borne pathogens in blood and splenic samples from dogs with splenic disease. Parasit Vectors (2017) 0.75
Extensive Shared Chemosensitivity between Malaria and Babesiosis Blood-Stage Parasites. Antimicrob Agents Chemother (2016) 0.75
Severe Babesia microti Infection in an Immunocompetent Host in Pennsylvania. J Investig Med High Impact Case Rep (2016) 0.75
Spontaneous splenic rupture due to Babesia microti infection: Case report and review of the literature. IDCases (2014) 0.75
Fatal Babesia canis canis infection in a splenectomized Estonian dog. Acta Vet Scand (2016) 0.75
Hematologic manifestations of babesiosis. Ann Clin Microbiol Antimicrob (2017) 0.75
Stimulation and quantification of Babesia divergens gametocytogenesis. Parasit Vectors (2016) 0.75
Solving Summer Fever in Early Pregnancy. J Gen Intern Med (2015) 0.75
Pro-inflammatory immune responses are associated with clinical signs and symptoms of human anaplasmosis. PLoS One (2017) 0.75
Elimination of Babesia microti Is Dependent on Intraerythrocytic Killing and CD4(+) T Cells. J Immunol (2017) 0.75
High-resolution melting PCR assay, applicable for diagnostics and screening studies, allowing detection and differentiation of several Babesia spp. infecting humans and animals. Parasitol Res (2017) 0.75
Babesia microti: From Mice to Ticks to an Increasing Number of Highly Susceptible Humans. J Clin Microbiol (2017) 0.75
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01
Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg Infect Dis (2011) 3.12
Human babesiosis. Infect Dis Clin North Am (2008) 2.12
Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11
Borrelia miyamotoi: The Newest Infection Brought to Us by Deer Ticks. Ann Intern Med (2015) 2.00
Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol (2003) 1.53
Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti. Nucleic Acids Res (2012) 1.49
Update on babesiosis. Interdiscip Perspect Infect Dis (2009) 1.39
Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study. Clin Infect Dis (2014) 1.39
Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. Transfusion (2012) 1.36
Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin Infect Dis (2010) 1.20
Hypersensitivity to ticks and Lyme disease risk. Emerg Infect Dis (2005) 1.19
Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States. Emerg Infect Dis (2014) 1.13
Entomologic and serologic evidence of zoonotic transmission of Babesia microti, eastern Switzerland. Emerg Infect Dis (2002) 1.10
Development of a real-time polymerase chain reaction assay for sensitive detection and quantitation of Babesia microti infection. Transfusion (2013) 1.05
Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice. Infect Immun (2002) 0.99
Confirmation of tick bite by detection of antibody to Ixodes calreticulin salivary protein. Clin Vaccine Immunol (2006) 0.99
One Health approach to identify research needs in bovine and human babesioses: workshop report. Parasit Vectors (2010) 0.99
Monitoring human babesiosis emergence through vector surveillance New England, USA. Emerg Infect Dis (2014) 0.97
Quantitative PCR for detection of Babesia microti in Ixodes scapularis ticks and in human blood. Vector Borne Zoonotic Dis (2013) 0.91
Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient. Malar J (2006) 0.91
Atovaquone and azithromycin treatment for babesiosis in an infant. Pediatr Infect Dis J (2007) 0.89
Whole genome mapping and re-organization of the nuclear and mitochondrial genomes of Babesia microti isolates. PLoS One (2013) 0.88
Colpodella spp.-like parasite infection in woman, China. Emerg Infect Dis (2012) 0.85
Babesiosis: similar to malaria but different. Pediatr Ann (2002) 0.83
Nosocomial transmission of human granulocytic anaplasmosis? JAMA (2008) 0.83
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion (2014) 0.82
Babesiosis in pregnancy. N Engl J Med (2003) 0.81
Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supply. Transfusion (2014) 0.80
The problem of transfusion-transmitted babesiosis. Transfusion (2009) 0.79
Transfusion-transmitted babesiosis: is it time to screen the blood supply? Curr Opin Hematol (2016) 0.78
Ehrlichiosis in children. Semin Pediatr Infect Dis (2002) 0.77
Long-term Lyme disease antibiotic therapy beliefs among New England residents. Vector Borne Zoonotic Dis (2011) 0.77
Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritis. Clin Vaccine Immunol (2007) 0.76
Borrelia miyamotoi. Ann Intern Med (2015) 0.75
Neurological manifestations of human babesiosis. Handb Clin Neurol (2013) 0.75